Jason Lettmann - 14 Mar 2025 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Shelly Pinto, by power of attorney
Issuer symbol
ALXO
Transactions as of
14 Mar 2025
Net transactions value
$0
Form type
4
Filing time
18 Mar 2025, 16:41:30 UTC
Previous filing
21 Feb 2025
Next filing
15 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALXO Common Stock Award $0 +42,000 +25% $0.000000 212,270 14 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares are represented by performance share units, or PSUs, and were awarded upon the achievement of certain performance metrics related to the positive results for ASPEN-06 clinical trials. Shares subject to the PSU vest on March 14, 2026.